We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cambridge Cognition Holdings Plc | LSE:COG | London | Ordinary Share | GB00B8DV9647 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 52.00 | 51.00 | 53.00 | 52.00 | 52.00 | 52.00 | 3,300 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 12.61M | -409k | -0.0117 | -44.44 | 18.12M |
TIDMCOG
Cambridge Cognition Holdings PLC
01 August 2018
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
CANTAB(R) incorporated in population health platform
The digital neuroscience company Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce a commercial collaboration with digital health provider Healthy Amplified, which sees the Company's CANTAB(R) technology incorporated into a newly launched population health platform.
Healthy Amplified bridges the communication gap between healthcare providers, trainers, parents and youth sports caregivers. The inclusion of the gold standard cognitive assessment technology expands its offering to adults, facilitating the standardised testing of cognitive abilities, with a specific focus on assessing traumatic brain injury, depression, and the early detection of cognitive impairment associated with Alzheimer's disease.
Under the collaboration, Healthy Amplified will act as a reseller of CANTAB products in US health markets, anticipating full rollout of its population health platform across 35 US Metropolitan Markets by the end of 2018.
Dr Steven Powell, CEO, Cambridge Cognition, said: "Through this collaboration we hope to widen the distribution channels of our medical software products to an established customer base in the US healthcare market."
William H. Nelson, CEO, Healthy Amplified, said: "By incorporating leading neurocognitive CANTAB technology, we are advancing our mission to provide population health management solutions available for adult populations."
Enquiries
Cambridge Cognition Holdings PLC Steven Powell, Chief Executive Tel: 01223 810 Officer 700 Noah Konig, Director of Marketing press@camcog.com finnCap Ltd (NOMAD and Joint Broker) Tel: 020 7220 Geoff Nash / Simon Hicks 0500 Alice Lane (Corporate Finance) (Corporate Broking) Dowgate Capital Stockbrokers Limited Tel: 020 3903 (Joint Broker) 7715 David Poutney / James Serjeant IFC Advisory Ltd (Financial PR Tel: 020 3934 and IR) 6630 Graham Herring / Miles Nolan / Zach Cohen
About Cambridge Cognition
Cambridge Cognition is a digital neuroscience company developing software products to better understand, detect and treat brain health conditions. The company's cognitive technologies are used to accelerate the research and development of new treatments, enhance understanding of the brain and accurately assess cognitive health in patients worldwide.
For more information, visit www.cambridgecognition.com
About Healthy Amplified
Headquartered in Chicago, IL, Healthy Amplified's cloud-based HIPAA solution aggregates medical history from multiple caregivers, and simplifies treatment collaboration between family, coaches, trainers and primary care physicians.
For more information, visit www.healthyamplified.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NRAWGUPUMUPRGMG
(END) Dow Jones Newswires
August 01, 2018 02:01 ET (06:01 GMT)
1 Year Cambridge Cognition Chart |
1 Month Cambridge Cognition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions